RecruitingNot ApplicableNCT03094026

Cognitive Training Intervention and Attitudes Towards Genetics

Intervention Strategies to Improve Cognitive Functioning in Hematologic Cancer Survivors After Hematopoietic Cell Transplantation


Sponsor

University of Alabama at Birmingham

Enrollment

60 participants

Start Date

Aug 21, 2017

Study Type

INTERVENTIONAL

Conditions

Summary

A pilot study to evaluate feasibility of enrollment of patients in an intervention to improve neurocognitive function in hematopoietic cell transplantation (HCT) survivors using the cognitive training Lumosity program. In addition, patients' interest in receiving information regarding genetic risk of cognitive impairment post-HCT will be measured.


Eligibility

Min Age: 21 Years

Inclusion Criteria4

  • ≥ 21 years old at time of allogeneic HCT performed at UAB
  • Outpatient and between 3 and 6 months post HCT
  • English speaking
  • Possess access to an internet-connected home computer

Exclusion Criteria3

  • History of pre-existing neurological disorder or documented major psychiatric disorder; significant auditory, visual, or motor impairments
  • Participated in neuropsychological intervention within the past 6 months
  • History of color blindness

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALLumosity

Computer-based online cognitive training program using the Lumosity cognitive training program.

BEHAVIORALLumosity (waitlist control)

Computer-based online cognitive training program using the Lumosity cognitive training program. The control group will receive the intervention after a waiting period of 12 weeks.


Locations(1)

University of Alabama at Birmingham

Birmingham, Alabama, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03094026


Related Trials